Montreux Equity Partners — 2010 Investments

1 investments dated 2010 · listed companies and verified rows first · show all

Pulmonx Corp.pulmonx.com in 𝕏NASDAQ: LUNGFeb 2010 · $32M

Pulmonx develops the Zephyr Valve, a bronchoscopic device used to treat patients with severe COPD/emphysema without surgery.

BiotechHealthtechMedical DevicesSan Jose, US

LAUREN CRISTINA(Executive Officer)inSri Radhakrishnan(Chief Technology Officer)inMICHAEL BAKER(Executive Officer, Director)inGlendon E. French(Chief Executive Officer and Director)Derrick Sung(Chief Operating Officer and Chief Financial Officer)inGeoffrey Beran Rose(Chief Commercial Officer)

Co-investorsBand of Angels HealthCap Kaiser Permanente Ventures Kleiner Perkins Latterell Venture Partners Ally Bridge Group

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.